TPG Asia GenPar VII Advisors, Inc. - Net Worth and Insider Trading
TPG Asia GenPar VII Advisors, Inc. Net Worth
The estimated net worth of TPG Asia GenPar VII Advisors, Inc. is at least $65 Million dollars as of 2025-06-06. TPG Asia GenPar VII Advisors, Inc. is the 2201 Interest of corporation controlled by you of Shanghai Bio-heart Biological Technology Co Ltd and owns about 20,753,025 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) stock worth over $65 Million. Details can be seen in TPG Asia GenPar VII Advisors, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that TPG Asia GenPar VII Advisors, Inc. has not made any transactions after 2021-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of TPG Asia GenPar VII Advisors, Inc.
TPG Asia GenPar VII Advisors, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, TPG Asia GenPar VII Advisors, Inc. owns 1 companies in total, including Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) .
Insider Ownership Summary of TPG Asia GenPar VII Advisors, Inc.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02185 | Shanghai Bio-heart Biological Technology Co Ltd | 2021-12-23 | 2201 Interest of corporation controlled by you |
TPG Asia GenPar VII Advisors, Inc. Latest Holdings Summary
TPG Asia GenPar VII Advisors, Inc. currently owns a total of 1 stock. TPG Asia GenPar VII Advisors, Inc. owns 20,753,025 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) as of December 23, 2021, with a value of $65 Million.
Latest Holdings of TPG Asia GenPar VII Advisors, Inc.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02185 | Shanghai Bio-heart Biological Technology Co Ltd | 2021-12-23 | 20,753,025 | 3.13 | 64,956,968 |
Holding Weightings of TPG Asia GenPar VII Advisors, Inc.
TPG Asia GenPar VII Advisors, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, TPG Asia GenPar VII Advisors, Inc. has made a total of 1 transactions in Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shanghai Bio-heart Biological Technology Co Ltd is the sale of 20,753,025 shares on December 23, 2021, which brought TPG Asia GenPar VII Advisors, Inc. around $0.
Insider Trading History of TPG Asia GenPar VII Advisors, Inc.
- 1
TPG Asia GenPar VII Advisors, Inc. Trading Performance
TPG Asia GenPar VII Advisors, Inc. Ownership Network
Ownership Network List of TPG Asia GenPar VII Advisors, Inc.
Ownership Network Relation of TPG Asia GenPar VII Advisors, Inc.
TPG Asia GenPar VII Advisors, Inc. Owned Company Details
What does Shanghai Bio-heart Biological Technology Co Ltd do?
Who are the key executives at Shanghai Bio-heart Biological Technology Co Ltd?
TPG Asia GenPar VII Advisors, Inc. is the 2201 Interest of corporation controlled by you of Shanghai Bio-heart Biological Technology Co Ltd. Other key executives at Shanghai Bio-heart Biological Technology Co Ltd include 2201 Interest of corporation controlled by you TPG Operating Group II, L.P. , 2201 Interest of corporation controlled by you TPG Asia GenPar VII, L.P. , and 2201 Interest of corporation controlled by you TPG Asia VII Finance, Limited Partnership .
Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) Insider Trades Summary
Over the past 18 months, TPG Asia GenPar VII Advisors, Inc. made no insider transaction in Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185). Other recent insider transactions involving Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) include a net sale of 208,500 shares made by TPG Operating Group II, L.P. , a net sale of 208,500 shares made by TPG Operating Group III, L.P. , and a net sale of 208,500 shares made by TPG Asia GenPar VII, L.P. .
In summary, during the past 3 months, insiders sold 1,876,500 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) in total and bought 0 shares, with a net sale of 1,876,500 shares. During the past 18 months, 1,876,500 shares of Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,876,500 shares.
Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Bio-heart Biological Technology Co Ltd Insider Transactions
TPG Asia GenPar VII Advisors, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for TPG Asia GenPar VII Advisors, Inc.. Currently GuruFocus does not have mailing address information for TPG Asia GenPar VII Advisors, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
